Tang, Kevin

Track

Insider profile

Tang, Kevin's trades of Aurinia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
429.22
Quantity 90,223 +1.9%
Value US$1,282,339
Transaction date
Purchase
Price
233.47
Quantity 56,835 +17.7%
Value US$3,690,503
Transaction date
Purchase
Price
132.77
Quantity 599 +41.5%
Value US$3,931,810
Transaction date
Purchase
Price
15.28
Quantity 171,760
Value US$2,624,493
Transaction date
Purchase
Price
15.28
Quantity 171,761 +343.5%
Value US$2,624,508
Transaction date
Purchase
Price
15.31
Quantity 262,682 +3.8%
Value US$4,021,661
Transaction date
Purchase
Price
15.35
Quantity 2,299 +0.0%
Value US$35,290
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02
B Purchase
90,223 +1.9%
429.22
US$1,282,339 		90,223 +1.9% 429.22 US$1,282,339
2026-06-03 2026-06-02
B Purchase
56,835 +17.7%
233.47
US$3,690,503 		56,835 +17.7% 233.47 US$3,690,503
2026-06-03 2026-06-01
B Purchase
599 +41.5%
132.77
US$3,931,810 		599 +41.5% 132.77 US$3,931,810
2026-06-03 2026-06-01
B Purchase
171,760
15.28
US$2,624,493 		171,760 15.28 US$2,624,493
2026-06-03 2026-06-01
B Purchase
50 +0.0%
15.34
US$767 		50 +0.0% 15.34 US$767
2026-06-03 2026-06-01
B Purchase
171,761 +343.5%
15.28
US$2,624,508 		171,761 +343.5% 15.28 US$2,624,508
2026-06-03 2026-05-29
B Purchase
262,682 +3.8%
15.31
US$4,021,661 		262,682 +3.8% 15.31 US$4,021,661
2026-06-03 2026-05-29
B Purchase
2,299 +0.0%
15.35
US$35,290 		2,299 +0.0% 15.35 US$35,290